FDA Adds Licenses of Simulations Plus's GastroPlus Software
Published: Oct 15, 2013
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that the U.S. Food and Drug Administration has added licenses of GastroPlus™ for use in the Office of Clinical Pharmacology.
Help employers find you! Check out all the jobs and post your resume.